TABLE 5.
Sex | Asthma outcome | Model with NC alone (r2) | Model with BMI percentile alone (r2) | Model with BMI percentile +NC (r2) | % variability in outcome attributable to NC (P-value)1 | Cohen’s f2 effect size |
---|---|---|---|---|---|---|
Female | ACT2 | 0.081 | 0.142 | 0.147 | 0.5% (0.60) | <0.01 |
ITG composite | 0.056 | 0.096 | 0.099 | 0.3% (0.68) | <0.01 | |
ITG functional | 0.046 | 0.093 | 0.094 | 0.1% (0.80) | <0.01 | |
ITG daytime | 0.068 | 0.039 | 0.070 | 3.2% (0.19) | 0.033 | |
ITG nighttime | 0.008 | 0.073 | 0.082 | 0.9% (0.49) | 0.01 | |
Male | ACT2 | 0.096 | 0.021 | 0.096 | 7.5% (0.029) | 0.083 |
ITG composite | 0.081 | 0.004 | 0.085 | 8.1% (0.028) | 0.093 | |
ITG functional | 0.081 | 0.017 | 0.081 | 6.4% (0.049) | 0.073 | |
ITG daytime | 0.050 | 0.011 | 0.050 | 3.9% (0.13) | 0.043 | |
ITG nighttime | 0.052 | 0.002 | 0.075 | 7.3% (0.037) | 0.083 |
BMI, body mass index; NC, neck circumference; ACT, asthma control test; ITG, integrated therapeutics group’s child asthma short form.
Likelihood-ratio P-value shown.
Analyses performed on square-transformed data.
By convention, a Cohen’s f2 effect size of 0.02, 0.15, and 0.35 are considered small, medium and large, respectively.